Category: COFEPRIS

  • Sorrento Reports Submission of MAA to COFEPRIS for COVI-STIX Rapid Detection Test

    Shots. The company has submitted MAA to COFEPRIS (the health regulatory authority for Mexico) for its COVI-STIX rapid diagnostic test to detect SARS-CoV-2 virus nucleocapsid antigen in nasal samples of patients The test provides results in 15min. with positive detection as quickly as 2min for patient samples with high viral load. Additionally, Sorrento is also […]